CSR/Corporate social responsibility

Adamed Donates Hybrid Cardiac Telerehabilitation Kits

9 May 2022

The initiative of Adamed Pharma is a response to the key challenges of contemporary medicine which include cardiovascular diseases – a major cause of mortality in Poland. The disease burden, which has increased due to the COVID-19 pandemic, is a challenge to the entire population. As part of the “New Heart” programme, Adamed will donate the total of 175 kits for hybrid cardiac telerehabilitation to 35 health facilities in Poland. Since the initiative began, the kits have been supplied to the first 9 facilities, namely:

  • Wojskowy Szpital Kliniczny in Lublin,
  • Oddział Rehabilitacji Kardiologicznej i Kardiologii Doświadczalnej Regionalnego Szpitala Specjalistycznego in Grudziądz,
  • "Pro-Medica" w Ełku Sp. z o.o.,
  • Mazowiecki Szpital Bródnowski w Warszawie Sp. z o.o.,
  • Śląskie Centrum Chorób Serca in Zabrze,
  • Kliniczny Szpital Wojewódzki Nr 2 im. Św. Jadwigi Królowej in Rzeszów,
  • Wojewódzki Szpital Specjalistyczny in Legnica,
  • Dolnośląskie Centrum Rehabilitacji i Ortopedii Sp. z o.o. in Kamienna Góra,
  • Szpital Zachodni im. Jana Pawła II in Grodzisk Mazowiecki.

Hybrid Cardiac Telerehabilitation

The kit for hybrid cardiac telerehabilitation consists of a smartphone with a dedicated mobile application, an ECG device, a blood pressure monitor and a scale. The kit comes with a license for software and technical support services that will be provided for 12 months from the launch of the service.

Hybrid cardiac telerehabilitation allows the patient to work out individually at any chosen place while healthcare professionals may remotely monitor the progress. This innovative solution allows the attending physician to monitor patient’s vital signs and compliance with recommendations during their training. It helps the patient significantly reduce the incidence of new episodes of the disease. A nine-week comprehensive hybrid telerehabilitation has been proven to significantly improve physical fitness and the quality of life in patients with heart failure as compared to the standard of care.[1] It is safe and simple to organize and implement.

Hybrid cardiac telerehabilitation is a necessary step in the management of patients with cardiovascular diseases and it should be initiated in all patients for whom it is indicated.Particularly during the pandemic, hybrid cardiac telerehabilitation preceded by phase 1 rehabilitation performed in inpatient setting is preferred. In the following phase, the patient is rehabilitated at home which is convenient and additionally reduces the risk of infection.[2] The benefits of this type of rehabilitation can be observed in people who have had a heart attack or a cardiac surgery as well as those suffering from chronic coronary syndromes and heart failure, among other conditions.

Details of the programme, which will last until 31 August 2022, and the rules of participation, can be found at www.sercenanowo.pl.


[2]https://www.rehabilitacjakardiologicznaptk.pl/news-item/rk-w-czasie-pandemii-covid-19-czesc-1-stanowisko 28/04/2020.